Hll Biotech Profile
Key Indicators
- Authorised Capital ₹ 285.00 Cr
as on 22-10-2024
- Paid Up Capital ₹ 274.89 Cr
as on 22-10-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 459.00 Cr
as on 22-10-2024
- Revenue -92.75%
(FY 2023)
- Profit -101.87%
(FY 2023)
- Ebitda -95.64%
(FY 2023)
- Net Worth -1.82%
(FY 2023)
- Total Assets -2.61%
(FY 2023)
About Hll Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 285.00 Cr and a paid-up capital of Rs 274.89 Cr.
The company currently has active open charges totaling ₹459.00 Cr.
The Key Managerial Personnel (KMP) at Hll Biotech Limited India are Jayakumar Lakshmi as COMPANY SECRETARY and Vijay Sistla as Ceo. Amitabh Soni, Roli Singh, Jaideep Mishra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290KL2012GOI030732
- Company No.
030732
- Company Classification
Private Limited Union Government Company
- Incorporation Date
12 Mar 2012
- Date of AGM
19 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hll Biotech Limited offer?
Hll Biotech Limited offers a wide range of products and services, including Syringes, Auto Disable Syringe.
Who are the key members and board of directors at Hll Biotech?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jayakumar Lakshmi | Company Secretary | 25-Sep-2024 | Current |
Vijay Sistla | CEO | 13-Sep-2021 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amitabh Soni | Nominee Director | 01-Apr-2022 | Current |
Roli Singh | Nominee Director | 19-Jan-2022 | Current |
Jaideep Mishra | Nominee Director | 29-Dec-2022 | Current |
Aruna Sarap | Nominee Director | 01-Apr-2022 | Current |
Vijay Sistla | Nominee Director and Ceo | Current |
Financial Performance and Corporate Structure Insights of Hll Biotech.
Hll Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 92.75% decrease. The company also saw a substantial fall in profitability, with a 101.87% decrease in profit. The company's net worth dipped by a decrease of 1.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hll Biotech?
In 2023, Hll Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Sbicap Trustee Company Limited Creation Date: 29 Jun 2017 | ₹309.00 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Jun 2016 | ₹50.00 Cr | Open |
State Bank Of Travancore Creation Date: 30 May 2016 | ₹100.00 Cr | Open |
How Many Employees Work at Hll Biotech?
Hll Biotech has a workforce of 99 employees as of Oct 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hll Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hll Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.